Viking Therapeutics, Inc.
US ˙ NasdaqCM ˙ US92686J1060

SecurityVKTX / Viking Therapeutics, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in VKTX / Viking Therapeutics, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Viking Therapeutics, Inc. (US:VKTX) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 330,100 shares of Viking Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F VIKING THERAPEUTICS COM 92686J106 0 -330,100 -100.00 0 -100.00
2025-11-13 2025-09-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 8,675 -0.83 0.0101
2025-08-14 2025-06-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 8,748 9.73 0.0107
2025-08-14 2025-03-31 13F/A-1 VIKING THERAPEUTICS COM 92686J106 330,100 -187,308 -36.20 7,972 -61.71 0.0099
2025-05-15 2025-03-31 13F VIKING THERAPEUTICS COM 92686J106 330,100 -187,308 7,972 0.0065
2025-02-14 2024-12-31 13F VIKING THERAPEUTICS COM 92686J106 517,408 -50,992 -8.97 20,820 -42.14 0.0253
2024-11-14 2024-09-30 13F VIKING THERAPEUTICS COM 92686J106 568,400 -306 -0.05 35,985 19.37 0.0388
2024-08-09 2024-06-30 13F VIKING THERAPEUTICS COM 92686J106 568,706 91,771 19.24 30,147 -22.92 0.0346
2024-05-14 2024-03-31 13F VIKING THERAPEUTICS COM 92686J106 476,935 146,835 44.48 39,109 536.64 0.0444
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 6,143 68.12 0.0071
2023-11-14 2023-09-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 3,654 -31.71 0.0046
2023-10-27 2023-06-30 13F/A-2 VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 5,351 -2.64 0.0061
2023-10-12 2023-06-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 330,100 0 5,351 0.0054
2023-08-14 2023-06-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 5,351 0.0054
2023-06-01 2023-03-31 13F/A-1 VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 5,496 77.12 0.0065
2023-05-15 2023-03-31 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 5,496 0.0050
2023-02-21 2022-12-31 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 3,103 245.55 0.0037
2022-11-14 2022-09-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 898 -5.87 0.0011
2022-08-17 2022-06-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 330,100 -1,948 -0.59 954 -4.22 0.0011
2022-08-15 2022-06-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 -1,948 954 0.0003
2022-05-16 2022-03-31 13F VIKING THERAPEUTICS COM 92686J106 332,048 0 0.00 996 -34.77 0.0008
2022-02-11 2021-12-31 13F Viking Therapeutics COM 92686J106 332,048 0 0.00 1,527 -26.76 0.0013
2021-11-12 2021-09-30 13F VIKING THERAPEUTICS COM 92686J106 332,048 0 0.00 2,085 4.83 0.0018
2021-08-13 2021-06-30 13F VIKING THERAPEUTICS COM 92686J106 332,048 0 0.00 1,989 -5.29 0.0016
2021-05-14 2021-03-31 13F VIKING THERAPEUTICS COM 92686J106 332,048 -597 -0.18 2,100 12.18 0.0030
2021-02-16 2020-12-31 13F VIKING THERAPEUTICS COM 92686J106 332,645 0 0.00 1,872 -3.31 0.0027
2020-11-13 2020-09-30 13F VIKING THERAPEUTICS COM 92686J106 332,645 0 0.00 1,936 -19.27 0.0033
2020-08-11 2020-06-30 13F VIKING THERAPEUTICS COM 92686J106 332,645 2,545 0.77 2,398 55.21 0.0041
2020-05-15 2020-03-31 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 1,545 -41.63 0.0032
2020-03-18 2019-12-31 13F/A-2 VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 2,647 16.56 0.0038
2020-02-28 2019-12-31 13F/A-1 VIKING THERAPEUTICS COM 92686J106 330,100 0 2,647 0.0038
2020-02-14 2019-12-31 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 2,647 3,321.7607
2019-11-14 2019-09-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 0 0.00 2,271 -17.12 0.0038
2019-11-06 2019-06-30 13F/A-2 VIKING THERAPEUTICS COM 92686J106 330,100 -72,206 -17.95 2,740 -31.48 0.0046
2019-09-24 2019-06-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 330,100 0 2,740 0.0047
2019-08-14 2019-06-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 -72,206 2,740
2019-05-15 2019-03-31 13F VIKING THERAPEUTICS COM 92686J106 402,306 -35,594 -8.13 3,999 19.37 0.0068
2019-02-15 2018-12-31 13F VIKING THERAPEUTICS COM 92686J106 437,900 61,100 16.22 3,350 -48.96 0.0065
2018-11-15 2018-09-30 13F VIKING THERAPEUTICS COM 92686J106 376,800 46,700 14.15 6,564 109.51 0.0107
2019-03-21 2018-06-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 330,100 330,100 3,133 0.0054
2018-08-14 2018-06-30 13F VIKING THERAPEUTICS COM 92686J106 330,100 330,100 3,133
2018-05-11 2018-03-31 13F VIKING THERAPEUTICS COM 92686J106 0 -2,100 -100.00 0 -100.00
2018-02-14 2017-12-31 13F VIKING THERAPEUTICS COM 92686J106 2,100 2,100 9 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.